Recursion

Recursion is a pioneering biotechnology company based in the UK, dedicated to transforming drug discovery through advanced technology and data science. The company leverages its unique platform to accelerate the identification of new therapeutic candidates, focusing on rare diseases and complex conditions that have historically been challenging to treat.

At the heart of Recursion’s mission is the integration of machine learning and high-throughput biology, enabling the analysis of vast datasets to uncover novel insights into disease mechanisms. This innovative approach not only enhances the efficiency of the drug development process but also significantly reduces the time and cost associated with bringing new treatments to market.

Recursion’s team comprises experts from diverse fields, including biology, engineering, and computer science, all united by a common goal: to improve patient outcomes through cutting-edge research and development. The company collaborates with leading academic institutions and pharmaceutical partners to expand its capabilities and reach.

In addition to its commitment to scientific excellence, Recursion places a strong emphasis on ethical practices and transparency in its operations. The company believes in fostering an inclusive culture that encourages creativity and collaboration among its employees.

Core Activities:

• Drug Discovery and Development
• Machine Learning and Data Analysis
• Collaboration with Academic and Industry Partners

Looking ahead, Recursion aims to revolutionise the landscape of medicine by harnessing the power of technology to unlock new possibilities in healthcare. With a vision to make a meaningful impact on patients’ lives, Recursion is at the forefront of the biopharmaceutical industry, driving innovation and change.